e-learning
resources
Vienna 2012
Monday, 03.09.2012
GOLD guidelines 2011: new assessment of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
GOLD assessment of COPD patients: Impact of symptoms assessment choice
H. Mullerova, N. Locantore, P. Jones (Uxbridge, London, United Kingdom; Research Triangle Park, United States Of America)
Source:
Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Session:
GOLD guidelines 2011: new assessment of COPD
Session type:
Oral Presentation
Number:
1650
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Mullerova, N. Locantore, P. Jones (Uxbridge, London, United Kingdom; Research Triangle Park, United States Of America). GOLD assessment of COPD patients: Impact of symptoms assessment choice. Eur Respir J 2012; 40: Suppl. 56, 1650
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Distribution of COPD patients in the GOLD assessment framework by exacerbations
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
Comparison of CAT and mMRC in evaluating clinical symptoms co-morbidity and medical resource utilization in COPD patients
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Measurement of COPD’s impact using the COPD assessment test (CAT) and symptom assessment differences between patients and family members
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
COPD comorbidities and risk assessment according to GOLD 2011 revision
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Impact of severity on three spirometric definitions of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002
Impact of comorbidities in COPD prognosys scores
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
Assessment of a disease management program for patients with asthma or COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 19s
Year: 2005
Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Impact of lung function impairment and exacerbation history on COPD patient-reported utility
Source: International Congress 2014 – COPD markers
Year: 2014
Combined COPD assessment using the new GOLD guidelines
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
Validity of COPD assessment test (CAT) in patients with cardiovascular co-morbidities
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Detection of acute health status deterioration among COPD patients by monitoring COPD assessment test score
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011
Impact of symptomatology in patients with GOLD stage I COPD
Source: Annual Congress 2010 - COPD: symptoms and staging
Year: 2010
How beneficial might be using the Lüscher colour test in the psychological assessment of COPD patients?
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015
Comparison of modified medical research council scale and COPD assessment test in subjects with COPD
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016
The relationship between dyspnea and detection of depression in COPD patients (pts)
Source: International Congress 2015 – Different data in COPD
Year: 2015
Impact of the GOLD 2011 guidelines on treatment regimens in COPD patients
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
COPD severity analysis according to current evaluation criteria – National survey
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept